can type 1 diabetics use glp-1 drugs are already famous for weight loss, but the 2025 OHSU-led trial pushed the story further. Adults with diabetes using automated insulin delivery and weekly semaglutide were far more Improved Heart and Kidney Outcomes

A small mug of soup

Understanding who should not take GLP-1 medications protects patient safety and ensures treatment aligns with medical history

September 2nd, 2025: September 2, 2025: JPML Ozempic Lawsuit Update The number of pending Ozempic lawsuits continues to grow, with 2,676 cases consolidated as of September 2025, compared to 2,190 in August

Well guide you through alternative options so you can continue your health journey without interruption

In recent years, GLP-1 receptor agonist injections such as semaglutide (Wegovy) or tirzepatide (Zepbound) have dominated the news as a promising medical therapy for weight loss